Private access surged from zero to 43.8% of total estimated use by April 2025. Media enquiries For enquiries about this story and interview requests please contact Michelle Smith: Phone: +61 410 116 257 Email: [email protected] How researchers quantified population-level trends in GLP-1 medicine use for the first time Data on subsidised access to GLP-1 medicines has been widely available in many countries, however, there has been a gap in information on private, non-subsidised use, making it harder for policymakers to make decisions on expanding access via Australias Pharmaceutical Benefits Scheme, said A/Prof
Take the First Step Toward Your Weight Loss Goals If youre ready to start your weight loss journey with Semaglutide or Tirzepatide, schedule your consultation at the LaVie Institute of Plastic Surgery today
Consuming foods that are rich in glutathione boosting properties doesnt pose any risk, but supplements taken intravenously or through injection may include some minor side effects
Semaglutide is not a substitute for thyroid hormone replacement medication In addition, it is important to continue taking any prescribed thyroid hormone replacement medication as directed by a healthcare provider
TRIUMPH-1s cohort started heavier 112.7 kg and BMI 40.0, against 106.4 and 38.2 in TRIUMPH-2
Try Research-ready cGMP film strips